| These highlights do not include all the information needed to use ABACAVIR TABLETS safely and effectively. See full prescribing information for ABACAVIR TABLETS. ABACAVIR tablets, for oral use Initial U.S. Approval: 1998 | Major Pharmaceuticals | 20260305 | 6 |
| These highlights do not include all the information needed to use ABACAVIR TABLETS safely and effectively. See full prescribing information for ABACAVIR TABLETS. ABACAVIR tablets, for oral use Initial U.S. Approval: 1998 | Safecor Health, LLC | 20260305 | 2 |
| These highlights do not include all the information needed to use ABACAVIR TABLETS safely and effectively. See full prescribing information for ABACAVIR TABLETS. ABACAVIR tablets USP, for oral use Initial U.S. Approval: 1998 | Coupler LLC | 20260119 | 2 |
| These highlights do not include all the information needed to use ABACAVIR AND LAMIVUDINE TABLETS safely and effectively. See full prescribing information for ABACAVIR AND LAMIVUDINE TABLETS. ABACAVIR and LAMIVUDINE tablets, for oral use Initial U.S. Approval: 2004 | Laurus Labs Limited | 20260112 | 4 |
| Abacavir Tablets, USP Rx Only These highlights do not include all the information needed to use ABACAVIR TABLETS safely and effectively. See full prescribing information for ABACAVIR TABLETS. Initial U.S. Approval: 1998 | AvPAK | 20260108 | 4 |
| These highlights do not include all the information needed to use ABACAVIR TABLETS safely and effectively. See full prescribing information for ABACAVIR TABLETS. ABACAVIR tablets, for oral use Initial U.S. Approval: 1998 | Mylan Institutional Inc. | 20250717 | 13 |
| These highlights do not include all the information needed to use ABACAVIR and LAMIVUDINE TABLETS safely and effectively. See full prescribing information for ABACAVIR and LAMIVUDINE TABLETS. ABACAVIR and LAMIVUDINE tablets, for oral use Initial U.S. Approval: 2004 | Camber Pharmaceuticals, Inc. | Hetero Labs Limited Unit V | 20250531 | 1 |
| These highlights do not include all the information needed to use ABACAVIR ORAL SOLUTION safely and effectively. See full prescribing information for ABACAVIR ORAL SOLUTION. ABACAVIR oral solution Initial U.S. Approval: 1998 | Rising Pharma Holdings, Inc. | Aurobindo Pharma Limited | 20250409 | 8 |
| These highlights do not include all the information needed to use ABACAVIR AND LAMIVUDINE TABLETS safely and effectively. See full prescribing information for ABACAVIR AND LAMIVUDINE TABLETS. ABACAVIR AND LAMIVUDINE TABLETS, for oral use Initial U.S. Approval: 2004 | Macleods Pharmaceuticals Limited | 20250303 | 2 |
| These highlights do not include all the information needed to use ABACAVIR TABLETS safely and effectively. See full prescribing information for ABACAVIR TABLETS. ABACAVIR tablets USP, for oral use Initial U.S. Approval: 1998 | Camber Pharmaceuticals, Inc. | Hetero Labs Limited Unit III | 20250109 | 6 |
| These highlights do not include all the information needed to use ABACAVIR TABLETS safely and effectively. See full prescribing information for ABACAVIR TABLETS. ABACAVIR tablets, for oral use Initial U.S. Approval: 1998 | American Health Packaging | 20240801 | 7 |
| These highlights do not include all the information needed to use TRIUMEQ and TRIUMEQ PD safely and effectively. See full prescribing information for TRIUMEQ and TRIUMEQ PD. TRIUMEQ (abacavir, dolutegravir, and lamivudine) tablets, for oral use TRIUMEQ PD (abacavir, dolutegravir, and lamivudine) tablets for oral suspension Initial U.S. Approval: 2014 | ViiV Healthcare Company | 20240708 | 30 |
| These highlights do not include all the information needed to use ABACAVIR AND LAMIVUDINE TABLETS safely and effectively. See full prescribing information for ABACAVIR AND LAMIVUDINE TABLETS. ABACAVIR and LAMIVUDINE tablets, for oral use Initial U.S. Approval: 2004 | Aurobindo Pharma Limited | 20240519 | 7 |
| These highlights do not include all the information needed to use ABACAVIR ORAL SOLUTION safely and effectively. See full prescribing information for ABACAVIR ORAL SOLUTION. ABACAVIR oral solution Initial U.S. Approval: 1998 | Aurobindo Pharma Limited | 20240508 | 6 |
| These highlights do not include all the information needed to use ABACAVIR TABLETS safely and effectively. See full prescribing information for ABACAVIR TABLETS. ABACAVIR tablets, for oral use Initial U.S. Approval: 1998 | Aurobindo Pharma Limited | 20240505 | 16 |
| These highlights do not include all the information needed to use ABACAVIR, LAMIVUDINE AND ZIDOVUDINE TABLETS safely and effectively. See full prescribing information for ABACAVIR, LAMIVUDINE AND ZIDOVUDINE TABLETS. ABACAVIR, LAMIVUDINE and ZIDOVUDINE tablets, for oral use Initial U.S. Approval: 2000 | Lupin Pharmaceuticals, Inc. | LUPIN LIMITED | 20231031 | 16 |
| These highlights do not include all the information needed to use ABACAVIR AND LAMIVUDINE TABLETS safely and effectively. See full prescribing information for ABACAVIR AND LAMIVUDINE TABLETS. ABACAVIR and LAMIVUDINE tablets, for oral use Initial U.S. Approval: 2004 | Lupin Pharmaceuticals, Inc. | LUPIN LIMITED | 20231030 | 14 |
| These highlights do not include all the information needed to use ZIAGEN safely and effectively. See full prescribing information for ZIAGEN. ZIAGEN (abacavir) tablets, for oral use ZIAGEN (abacavir) oral solution Initial U.S. Approval: 1998 | ViiV Healthcare Company | 20230929 | 32 |
| These highlights do not include all the information needed to use ABACAVIR TABLETS safely and effectively. See full prescribing information for ABACAVIR TABLETS. ABACAVIR tablets USP, for oral use Initial U.S. Approval: 1998 | XLCare Pharmaceuticals Inc. | Evaric Pharmaceuticals Inc | 20230116 | 3 |
| These highlights do not include all the information needed to use ABACAVIR AND LAMIVUDINE TABLETS safely and effectively. See full prescribing information for ABACAVIR AND LAMIVUDINE TABLETS ABACAVIR and LAMIVUIDNE Tablets, for oral use Initial U.S. Approval:2004 | Cipla USA Inc. | Cipla Ltd. Patalganga unit II | 20220118 | 8 |
| These highlights do not include all the information needed to use ABACAVIR TABLETS safely and effectively. See full prescribing information for ABACAVIR TABLETS . ABACAVIR tablets, for oral use Initial U.S. Approval: 1998 | Mylan Pharmaceuticals Inc. | 20210108 | 12 |
| These highlights do not include all the information needed to use ABACAVIR TABLETS safely and effectively. See full prescribing information for ABACAVIR TABLETS. ABACAVIR tablets, for oral use Initial U.S. Approval: 1998 | Cipla USA Inc. | Cipla Patalganga | Cipla Kurkumbh | Mylan-Laboratories Limited | 20201224 | 9 |
| HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ABACAVIR ORAL SOLUTION safely and effectively. See full prescribing information for ABACAVIR ORAL SOLUTION. ABACAVIR oral solution Initial U.S. Approval: 1998 | Camber Pharmaceuticals, Inc. | Hetero Labs Limited Unit III | 20170913 | 2 |
| These highlights do not include all the information needed to use TRIZIVIR safely and effectively. See full prescribing information for TRIZIVIR. TRIZIVIR (abacavir sulfate, lamivudine, and zidovudine) Tablets, for oral use Initial U.S. Approval: 2000 | State of Florida DOH Central Pharmacy | 20140424 | 2 |
| These highlights do not include all the information needed to use abacavir tablets safely and effectively. See full prescribing information for abacavir tablets. Abacavir Tablets, USP for Oral Use Initial U.S. Approval: 1998 | State of Florida DOH Central Pharmacy | 20130808 | 1 |
| EPZICOM ® (abacavir sulfate and lamivudine) Tablets | Physicians Total Care, Inc. | 20100701 | 1 |
| EPZICOM ® (abacavir sulfate and lamivudine) Tablets | State of Florida DOH Central Pharmacy | 20100511 | 2 |
| These highlights do not include all the information needed to use ZIAGEN safely and effectively. See full prescribing information for ZIAGEN. ZIAGEN ® (abacavir sulfate) Tablets and Oral Solution Initial U.S. Approval: 1998 | State of Florida DOH Central Pharmacy | 20100413 | 1 |